Pharmacy Benefit Manager Accountability Study Act of 2021
Latest action · Feb 8, 2021 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 8, 2021
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Pharmacy Benefit Manager Accountability Study Act of 2021
This bill requires the Government Accountability Office to report on the role of pharmacy benefit managers in the pharmaceutical supply chain and recommend legislative actions to lower the cost of prescription drugs. The report must address the use of rebates and fees, the average prior authorization approval time, and the use of step therapy within the 10 largest pharmacy benefit managers.
Cosponsors 1
Members who signed on, in the order they did. All signed on Feb 8, 2021.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-IN | Mike Braun | Original | Feb 8, 2021 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Health, Education, Labor, and Pensions Committee | Referred Feb 9, 2021 |
Actions 2
Everything that happened, newest first.
- Feb 8, 2021Introduced in Senate
- Feb 8, 2021Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Printed hearings 2
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| S. Hrg. 117-836 | ENSURING FAIRNESS AND TRANSPARENCY IN THE MARKETS OF PRESCRIPTION DRUGS122 pages | Commerce, Science, and Transportation Committee | May 5, 2022 |
| S. Hrg. 117-822 | A PRESCRIPTION FOR CHANGE: CRACKING DOWN ON ANTICOMPETITIVE CONDUCT IN PRESCRIPTION DRUG MARKETS147 pages | Judiciary Committee | Jul 13, 2021 |
Related bills 3
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 1532 | Pharmacy Benefit Manager Accountability Study Act of 2019 | Reintroduction of | May 16, 2019 |
| HR 1829 | Pharmacy Benefit Manager Accountability Study Act of 2021 | Identical bill | Mar 12, 2021 |
| S 4293 | Pharmacy Benefit Manager Transparency Act of 2022 | Related bill | Dec 14, 2022 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to require the Government Accountability Office to study the role pharmaceutical benefit managers play in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.
- Short Title(s) as Introduced
- Pharmacy Benefit Manager Accountability Study Act of 2021
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Feb 8, 2021Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
